Acne, Is It a Problem for You?

Last year, you mentioned that eligo entered into a research and option agreement with g s k to develop a crisper based approach to treating acney. This's a deal worth up to 224 million in license fees and potential milestones, as well as royalties on sales. Most of the hackne are drugs available in the market; they only provide symptomatic treatment, and they really don't cure the condition. There is also no treatment in the market that address this acne associative despises.

Transcript

Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.